Mourikis D, Chatziioannou A, Antoniou A, Kehagias D, Gikas D, Vlahos L
Department of Radiology, Areteion Hospital, Athens University, Vas. Softas, Greece.
Eur J Radiol. 1999 Dec;32(3):153-9. doi: 10.1016/s0720-048x(98)00179-x.
Current management of renal angiomyolipomas (AMLs) include observation, transcatheter embolization and partial or total nephrectomy. Patients symptoms and size of the lesion are the determinants for the choice of the treatment. In general symptomatic or greater than 8 cm masses require intervention. A retrospective study of five patients presented with symptomatic lesions and treated with selective transcatheter embolization, over a 3 year period was performed in our hospital. A total of eight embolizations were performed, all on an emergency basis due to retroperitoneal bleeding or significant hematuria. Surgical intervention was necessary in one case, due to massive rebleeding on the fourth post-procedural day. Two patients rebled within 6 months and 2 years respectively, and were managed successfully with additional embolization. The remaining two patients are still asymptomatic 26 and 18 months after the successful initial result. Experience with this procedure is reported on with emphasis to the clinical outcome. It is believed that selective arterial embolization should be the standard initial therapy for symptomatic renal AMLs.
肾血管平滑肌脂肪瘤(AMLs)目前的治疗方法包括观察、经导管栓塞以及部分或全肾切除术。患者的症状和病变大小是治疗方法选择的决定因素。一般来说,有症状的或大于8厘米的肿块需要进行干预。我院对5例有症状性病变并接受选择性经导管栓塞治疗的患者进行了为期3年的回顾性研究。总共进行了8次栓塞,均因腹膜后出血或大量血尿而在紧急情况下进行。1例患者在术后第4天因大量再次出血而需要进行手术干预。2例患者分别在6个月和2年后再次出血,并通过额外的栓塞成功处理。其余2例患者在首次成功治疗后26个月和18个月仍无症状。本文报告了该治疗方法的经验,并重点阐述了临床结果。据信,选择性动脉栓塞应成为有症状性肾AMLs的标准初始治疗方法。